Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects

被引:271
|
作者
Szabo, C [1 ]
Lim, LHK [1 ]
Cuzzocrea, S [1 ]
Getting, SJ [1 ]
Zingarelli, B [1 ]
Flower, RJ [1 ]
Salzman, AL [1 ]
Perretti, M [1 ]
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP MED COLL, COLL MED, WILLIAM HARVEY RES INST, LONDON EC1M 6BQ, ENGLAND
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1997年 / 186卷 / 07期
基金
英国惠康基金;
关键词
D O I
10.1084/jem.186.7.1041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cytotoxic cycle triggered by DNA single-strand breakage and poly (ADP-ribose) synthetase activation has been shown to contribute to the cellular injury during various forms of oxidant stress in vitro. The aim of this study was to investigate the role of poly (ADP-ribose) synthetase (PARS) in the process of neutrophil recruitment and in development of local and systemic inflammation. In pharmacological studies, PARS was inhibited by 3-aminobenzamide (10-20 mg/kg) in rats and mice. In other sets of studies, inflammatory responses in PARS(-/-) mice were compared with the responses in corresponding wild-type controls. Inhibition of PARS reduced neutrophil recruitment and reduced the extent of edema in zymosan-and carrageenan-triggered models of local inflammation. Moreover, inhibition of PARS prevented neutrophil recruitment, and reduced organ injury in rodent models of inflammation and multiple organ failure elicited by intraperitoneal injection of zymosan. Inhibition of PARS also reduced the extent of neutrophil emigration across murine mesenteric postcapillary venules. This reduction was due to an increased rate of adherent neutrophil detachment from the endothelium, promoting their reentry into the circulation. Taken together, our results demonstrate that PARS inhibition reduces local and systemic inflammation. Part of the antiinflammatory effects of PARS inhibition is due to reduced neutrophil recruitment, which may be related to maintained endothelial integrity.
引用
收藏
页码:1041 / 1049
页数:9
相关论文
共 50 条
  • [1] POLY(ADP-RIBOSE) SYNTHETASE
    UEDA, K
    ZHANG, JY
    HAYAISHI, O
    METHODS IN ENZYMOLOGY, 1984, 106 : 500 - 504
  • [2] Role of poly(ADP-ribose) synthetase in pulmonary leukocyte recruitment
    Kiefmann, R
    Heckel, K
    Dörger, M
    Schenkat, S
    Stoeckelhuber, M
    Wesierska-Gadek, J
    Goetz, AE
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 285 (05) : L996 - L1005
  • [3] CELLULAR EFFECTS OF POLY(ADP-RIBOSE) SYNTHETASE INHIBITORS
    PURNELL, MR
    KIDWELL, WR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 286 - 286
  • [4] HISTONE IS AN ACTIVATOR OF PURIFIED POLY(ADP-RIBOSE) SYNTHETASE, NOT AN ACCEPTOR OF POLY(ADP-RIBOSE)
    EDSON, CM
    OKAYAMA, H
    FUKUSHIMA, M
    HAYAISHI, O
    FEDERATION PROCEEDINGS, 1976, 35 (07) : 1722 - 1722
  • [5] POLY(ADP-RIBOSE) SYNTHETASE, A MAIN ACCEPTOR OF POLY(ADP-RIBOSE) IN ISOLATED-NUCLEI
    OGATA, N
    UEDA, K
    KAWAICHI, M
    HAYAISHI, O
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1981, 256 (09) : 4135 - 4137
  • [6] Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis
    Zingarelli, B
    Szasó, C
    Salzman, AL
    GASTROENTEROLOGY, 1999, 116 (02) : 335 - 345
  • [7] Blockade of poly (ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis
    Zingarelli, B
    Szabó, C
    Salzman, AL
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A48 - A48
  • [8] Inhibition of poly(ADP-ribose) synthetase (PARS) attenuates LPS-induced pulmonary vasomotor dysfunction
    Pulido, EJ
    Shames, BD
    Barton, HA
    Bensard, DD
    McIntyre, RC
    SHOCK, 1999, 11 : 20 - 20
  • [9] INHIBITION OF POLY(ADP-RIBOSE) SYNTHETASE POTENTIATES CELL DACARBAZINE CYTOTOXICITY
    LONN, U
    LONN, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (03) : 1089 - 1094
  • [10] THE ROLE OF POLY(ADP-RIBOSE) SYNTHETASE IN THE BIOLOGICAL EFFECTS OF BENZAMIDES
    PURNELL, MR
    LUNN, JM
    HARRIS, AL
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 180 - 180